New Federal Contractors — August 07, 2026

Merck won a $236.3M cost-plus contract (2017-2027) and a $155.8M firm-fixed-price contract (2024-2034) from HHS/BARDA for biotechnology R&D and ERVEBO procurement, signaling deep government commitment to pandemic preparedness and providing long-term, stable revenue streams.

AT&T's competitive win for a 12-year domestic telecommunications task order from the Department of State, with a total potential value of $1.17 billion, provides a predictable, long-term revenue stream from a stable civilian agency.

SENTURE's $105.6 million firm-fixed-price delivery order from the DOT's FMCSA for CIRIS services is fully outlayed, reducing payment risk and providing a predictable revenue stream through August 2025.

The $388.5 million NASA contract for ARCTIC SLOPE TECHNICAL SERVICES, INC. ended in August 2022, meaning this significant revenue stream has concluded and offers no forward-looking growth for the company.

Merck Sharp & Dohme LLC accounts for $392.1 million (31%) of the total $1.26 billion in awards, creating significant single-entity concentration risk for investors tracking government exposure.

Suffolk Construction's $88.2 million firm-fixed-price VA hospital boiler replacement contract (2026-2029) carries cost overrun risk, as any construction cost increases are borne by the contractor.

Whitney Bradley & Brown's $108 million firm-fixed-price GSA contract for defense aircraft R&D has no outlays to date, creating uncertainty about revenue recognition and execution progress.

The digest is heavily weighted toward civilian agencies (5 of 7 contracts), with only 2 defense-related awards. This may limit exposure to potential defense budget growth, especially under a Continuing Resolution scenario.

Merck's dual HHS/BARDA contracts provide a platform for follow-on biodefense awards, given the government's sustained focus on pandemic preparedness and the company's established relationship with BARDA.

AT&T's $1.17B State Department telecom ceiling suggests significant potential for option exercises, which would expand the company's government services revenue and demonstrate agency confidence.

SENTURE LLC's fully funded $105.6M DOT contract positions the company for follow-on work with the FMCSA as the contract approaches its August 2025 end date, given the agency's ongoing need for IT support.

HHS/BARDA awards to Merck ($392.1M) represent 31% of total digest value, underscoring sustained government investment in biodefense and pharmaceutical preparedness as a top civilian priority.

AT&T's $182M State Department telecom award and SENTURE's $105.6M DOT IT contract demonstrate ongoing civilian agency investment in telecommunications and IT infrastructure modernization.

Only 2 of 7 contracts ($196.1M, or 15.5% of total value) are defense-related, suggesting a potential lull in defense contract awards or a shift toward civilian priorities in this period.

{"entity" => "Merck & Co., Inc.", "reason" => "Dual HHS/BARDA awards ($392.1M) represent 31% of digest value; option exercises are key catalysts.", "trigger" => "Exercise of $72.9M in combined contract options"}

{"entity" => "AT&T Enterprises, LLC", "reason" => "$1.17B ceiling on State Department telecom contract offers significant upside if options are exercised.", "trigger" => "Option exercise announcements through 2032"}

{"entity" => "SENTURE LLC", "reason" => "Fully funded $105.6M DOT contract ending August 2025; re-compete is a key catalyst.", "trigger" => "FMCSA re-compete or extension announcement"}

{"entity" => "Arctic Slope Regional Corporation", "reason" => "Completed $388.5M NASA contract creates a revenue gap; watch for new wins to fill it.", "trigger" => "New contract awards from NASA or other agencies"}

{"entity" => "Serco Limited", "reason" => "Whitney Bradley & Brown's $108M GSA contract has no outlays; execution progress is uncertain.", "trigger" => "Outlay data updates on USASpending.gov"}